Advances in Clinical and Experimental Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2021-06-07 挣扎的小硕硕

审稿速度:2.0 | 投稿命中率:75.0
经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收

74 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2019-02-17 duantianbing_41262774

ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？

155 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2022-08-26 ms5000001087850399

这个投稿的链接为什么进不去啊，大家有投稿链接吗？

75 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2019-05-23 duantianbing_41262774

各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？

162 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2019-01-13 120b1094m19(暂无昵称)

万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表:
我的2015年接收的文章，上个月见刊

1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊

166 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2021-12-29 Gym璨烨

我是写那种格式的摘要比较好？

64 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2017-12-07 1500 mutation

我的2015年接收的文章，上个月见刊

246 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2017-08-26 liuchuxin

请问从接收到见刊要多久？怎么催可以快点发表出来？

240 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2019-01-13 120b1094m19(暂无昵称)

请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表:
我的2015年接收的文章，上个月见刊

1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊

128 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=971651, encodeId=11799e1651ec, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：2021.03.26 投出一篇综述 2021.05.04 小修 2021.06.07 接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230530/9e9e59acc0944ac59084af44dd4cbd04/63a72e5f377a433f8eaa02d3b314c533.jpg, createdBy=de935401089, createdName=挣扎的小硕硕, createdTime=Mon Jun 07 22:33:06 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566880, encodeId=3bd956688098, content= ADV CLIN EXP MED的杂志主页和投稿网站均无法打开？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=155, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Sun Feb 17 16:39:00 CST 2019, time=2019-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241185, encodeId=7c371241185e8, content=这个投稿的链接为什么进不去啊，大家有投稿链接吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82e48294406, createdName=ms5000001087850399, createdTime=Fri Aug 26 16:59:14 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571410, encodeId=059c5e141035, content=各位大神，2018年10月接收的文章，2019年2月交钱，估计啥时候能出proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73da2228386, createdName=duantianbing_41262774, createdTime=Thu May 23 23:28:00 CST 2019, time=2019-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565527, encodeId=e4c656552e94, content=万分感谢！！！1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100824, encodeId=d4fa1100824a3, content=我是写那种格式的摘要比较好？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549807, encodeId=011454980e6e, content=我的2015年接收的文章，上个月见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26991668940, createdName=1500 mutation, createdTime=Thu Dec 07 16:28:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545951, encodeId=f43b545951db, content=请问从接收到见刊要多久？怎么催可以快点发表出来？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29e21688231, createdName=liuchuxin, createdTime=Sat Aug 26 22:36:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565526, encodeId=4215565526e0, content=请问您的文章接受后多久拿到清样的1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, beContent=1500 mutation 2017-12-07 16:28:00 发表: 我的2015年接收的文章，上个月见刊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ff32200090, createdName=120b1094m19(暂无昵称), createdTime=Sun Jan 13 00:00:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2131653, encodeId=40762131653d9, content=审稿速度:6.0 偏重的研究方向：肿瘤相关 经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/c0bf527bb0d44e4ea914fe4bf3c4c254/c51e519698f740ed9b1a6a43858b61da.JPG, createdBy=09431704567, createdName=lucky xing, createdTime=Thu May 11 17:49:10 CST 2023, time=2023-05-11, status=1, ipAttribution=陕西省)]

2023-05-11 lucky xing 来自陕西省

审稿速度:6.0
偏重的研究方向：肿瘤相关
经验分享：一点多的杂志，审稿审了六个多月，意见一大堆，补了很多实验还拒稿了，感觉杂志一般，不友好

33 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务